A. Leprêtre

652 total citations
17 papers, 372 citations indexed

About

A. Leprêtre is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, A. Leprêtre has authored 17 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Virology. Recurrent topics in A. Leprêtre's work include HIV/AIDS drug development and treatment (7 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (5 papers). A. Leprêtre is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (5 papers). A. Leprêtre collaborates with scholars based in France, Senegal and Romania. A. Leprêtre's co-authors include Sophie Matheron, Françoise Brun‐Vézinet, Florence Damond, Pauline Campa, Pierre‐Marie Girard, Cristian Apetrei, Sandrine Souquière, François Simon, Geneviève Chêne and Roger Salamon and has published in prestigious journals such as The Lancet, CHEST Journal and Journal of Clinical Microbiology.

In The Last Decade

A. Leprêtre

17 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Leprêtre France 9 241 196 164 34 29 17 372
Louis Guida United States 7 242 1.0× 117 0.6× 150 0.9× 29 0.9× 11 0.4× 8 365
Wirach Maek-a-nantawat Thailand 11 208 0.9× 95 0.5× 150 0.9× 14 0.4× 56 1.9× 28 395
S Sabally Gambia 10 211 0.9× 252 1.3× 153 0.9× 14 0.4× 17 0.6× 10 442
Samuel Adeniyi‐Jones United States 11 203 0.8× 93 0.5× 158 1.0× 37 1.1× 51 1.8× 15 478
Anna Pierce Australia 10 221 0.9× 83 0.4× 161 1.0× 14 0.4× 25 0.9× 27 399
Donatella Concetta Cibelli Italy 10 117 0.5× 64 0.3× 98 0.6× 67 2.0× 8 0.3× 18 230
Ajantha Rhodes Australia 12 128 0.5× 213 1.1× 94 0.6× 41 1.2× 32 1.1× 38 408
Giovanni Battista Buccoliero Italy 11 157 0.7× 162 0.8× 104 0.6× 18 0.5× 11 0.4× 31 303
C Joline United States 5 98 0.4× 61 0.3× 99 0.6× 28 0.8× 35 1.2× 8 268
Maria Christine Thurnheer Switzerland 8 150 0.6× 60 0.3× 142 0.9× 64 1.9× 17 0.6× 16 304

Countries citing papers authored by A. Leprêtre

Since Specialization
Citations

This map shows the geographic impact of A. Leprêtre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Leprêtre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Leprêtre more than expected).

Fields of papers citing papers by A. Leprêtre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Leprêtre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Leprêtre. The network helps show where A. Leprêtre may publish in the future.

Co-authorship network of co-authors of A. Leprêtre

This figure shows the co-authorship network connecting the top 25 collaborators of A. Leprêtre. A scholar is included among the top collaborators of A. Leprêtre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Leprêtre. A. Leprêtre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Isernia, Valentina, Bao Phung, A. Leprêtre, et al.. (2020). Pre-exposure HIV prophylaxis (PrEP) among transgender women: 3 years of follow-up in a university hospital in Paris. Sexually Transmitted Infections. 97(6). 465–466. 3 indexed citations
2.
Couffignal, Camille, Aurélie Etienne, Cédric Laouenan, et al.. (2019). Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris. AIDS Care. 32(7). 811–817. 2 indexed citations
3.
Leprêtre, A., Karine Lacombe, Coumba Touré Kane, et al.. (2015). Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study. Journal of the International AIDS Society. 18(1). 19888–19888. 25 indexed citations
4.
Ndiaye, Oumar, Joël Gozlan, Halimatou Diop‐Ndiaye, et al.. (2015). Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal. Journal of Medical Virology. 89(3). 484–488. 4 indexed citations
5.
Raguin, G, et al.. (2011). Drug use and HIV in West Africa: a neglected epidemic. Tropical Medicine & International Health. 16(9). 1131–1133. 14 indexed citations
6.
Plessier, Aurélie, Anne Gervais, Pierre‐Emmanuel Rautou, et al.. (2009). OL-041 Non-cirrhotic portal hypertension (NCPHT) in 15 patients with HIV: characteristics, outcome and prognosis. International Journal of Infectious Diseases. 13. S43–S43. 2 indexed citations
7.
Olivier, Nicolas, et al.. (2008). Le réentraînement à l’effort de la lombalgie chronique nécessite-t-il un renforcement musculaire isocinétique quotidien du tronc ?. Annales de Réadaptation et de Médecine Physique. 51(4). 284–291. 7 indexed citations
8.
Matheron, Sophie, Sophie Pueyo, Florence Damond, et al.. (2003). Factors associated with clinical progression in HIV-2 infected-patients. AIDS. 17(18). 2593–2601. 76 indexed citations
9.
Damond, Florence, Cristian Apetrei, David L. Robertson, et al.. (2001). Variability of Human Immunodeficiency Virus Type 2 (HIV-2) Infecting Patients Living in France. Virology. 280(1). 19–30. 60 indexed citations
10.
Damond, Florence, Diane Descamps, Isabelle Farfara, et al.. (2001). Quantification of Proviral Load of Human Immunodeficiency Virus Type 2 Subtypes A and B Using Real-Time PCR. Journal of Clinical Microbiology. 39(12). 4264–4268. 46 indexed citations
11.
Damond, Florence, Ibtissam Loussert-Ajaka, Cristian Apetrei, et al.. (1998). Highly Sensitive Method for Amplification of Human Immunodeficiency Virus Type 2 DNA. Journal of Clinical Microbiology. 36(3). 809–811. 22 indexed citations
12.
13.
Cabié, André, et al.. (1992). [Visceral leishmaniasis in HIV infection. A totally opportunistic infection].. PubMed. 21(35). 1658–62. 16 indexed citations
14.
15.
Camus, Françoise, et al.. (1991). Pulmonary Tolerance of Prophylactic Aerosolized Pentamidine in Human Immunodeficiency Virus-Infected Patients*. CHEST Journal. 99(3). 609–612. 8 indexed citations
16.
Châtelain, A., et al.. (1990). Development of adenylate cyclase activity in rat adrenal glands during the perinatal period. Journal of Endocrinology. 126(2). 211–216. 8 indexed citations
17.
Girard, Pierre‐Marie, C. Gaudebout, Françoise Camus, et al.. (1989). PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA RELAPSE BY PENTAMIDINE AEROSOL IN ZIDOVUDINE-TREATED AIDS PATIENTS. The Lancet. 333(8651). 1348–1353. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis Guida Breakdown of academic impact, for papers by Wirach Maek-a-nantawat Breakdown of academic impact, for papers by S Sabally Breakdown of academic impact, for papers by Samuel Adeniyi‐Jones Breakdown of academic impact, for papers by Anna Pierce Breakdown of academic impact, for papers by Donatella Concetta Cibelli Breakdown of academic impact, for papers by Ajantha Rhodes Breakdown of academic impact, for papers by Giovanni Battista Buccoliero Breakdown of academic impact, for papers by C Joline Breakdown of academic impact, for papers by Maria Christine Thurnheer
Rankless by CCL
2026